JP5632580B2 - 脈管アクセスを改善するための方法および組成物 - Google Patents

脈管アクセスを改善するための方法および組成物 Download PDF

Info

Publication number
JP5632580B2
JP5632580B2 JP2008518189A JP2008518189A JP5632580B2 JP 5632580 B2 JP5632580 B2 JP 5632580B2 JP 2008518189 A JP2008518189 A JP 2008518189A JP 2008518189 A JP2008518189 A JP 2008518189A JP 5632580 B2 JP5632580 B2 JP 5632580B2
Authority
JP
Japan
Prior art keywords
cells
implantable material
graft
cell
transport medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2008518189A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008546406A (ja
JP2008546406A5 (enExample
Inventor
ヘレン マリー ニュージェント，
ヘレン マリー ニュージェント，
エレザ エーデルマン，
エレザ エーデルマン，
アヌパン ダラル，
アヌパン ダラル，
スティーブ ボリンジャー，
スティーブ ボリンジャー，
スコット エパリー，
スコット エパリー，
Original Assignee
シャイア リジェネラティブ メディシン， インコーポレイテッド
シャイア リジェネラティブ メディシン， インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2005/043967 external-priority patent/WO2006062909A2/en
Application filed by シャイア リジェネラティブ メディシン， インコーポレイテッド, シャイア リジェネラティブ メディシン， インコーポレイテッド filed Critical シャイア リジェネラティブ メディシン， インコーポレイテッド
Publication of JP2008546406A publication Critical patent/JP2008546406A/ja
Publication of JP2008546406A5 publication Critical patent/JP2008546406A5/ja
Application granted granted Critical
Publication of JP5632580B2 publication Critical patent/JP5632580B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/069—Vascular Endothelial cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3808—Endothelial cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Botany (AREA)
  • Transplantation (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • External Artificial Organs (AREA)
JP2008518189A 2005-06-21 2006-06-05 脈管アクセスを改善するための方法および組成物 Expired - Fee Related JP5632580B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US69270805P 2005-06-21 2005-06-21
US60/692,708 2005-06-21
USPCT/US2005/043967 2005-12-06
PCT/US2005/043967 WO2006062909A2 (en) 2004-12-08 2005-12-06 Methods and compositions for enhancing vascular access
PCT/US2006/021755 WO2007001744A2 (en) 2005-06-21 2006-06-05 Methods and compositions for enhancing vascular access

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012133043A Division JP2012166084A (ja) 2005-06-21 2012-06-12 脈管アクセスを改善するための方法および組成物

Publications (3)

Publication Number Publication Date
JP2008546406A JP2008546406A (ja) 2008-12-25
JP2008546406A5 JP2008546406A5 (enExample) 2009-07-16
JP5632580B2 true JP5632580B2 (ja) 2014-11-26

Family

ID=39892157

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008518189A Expired - Fee Related JP5632580B2 (ja) 2005-06-21 2006-06-05 脈管アクセスを改善するための方法および組成物
JP2012133043A Withdrawn JP2012166084A (ja) 2005-06-21 2012-06-12 脈管アクセスを改善するための方法および組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012133043A Withdrawn JP2012166084A (ja) 2005-06-21 2012-06-12 脈管アクセスを改善するための方法および組成物

Country Status (10)

Country Link
US (2) US20090035346A1 (enExample)
EP (2) EP2361591A3 (enExample)
JP (2) JP5632580B2 (enExample)
CN (3) CN101257861B (enExample)
AU (1) AU2006262682B2 (enExample)
CA (2) CA2612751A1 (enExample)
ES (1) ES2541684T3 (enExample)
IL (2) IL188263A (enExample)
SG (2) SG161258A1 (enExample)
WO (1) WO2007001744A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2926510B2 (ja) 1990-08-09 1999-07-28 京都電子工業株式会社 アンモニア濃度測定装置

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006238892B2 (en) 2005-04-21 2011-01-27 Massachusetts Institute Of Technology Materials and methods for altering an immune response to exogenous and endogenous immunogens, including syngeneic and non-syngeneic cells, tissues or organs
US20090035346A1 (en) 2005-06-21 2009-02-05 Pervasis Therpeutics, Inc. Methods and Compositions for Enhancing Vascular Access
WO2008057590A2 (en) * 2006-11-07 2008-05-15 Pervasis Therapeutics, Inc. Methods and compositions for modulating tissue modeling
US20100092532A1 (en) * 2006-11-07 2010-04-15 Helen Marie Nugent Materials and Methods for Treating and Managing Angiogenesis-Mediated Diseases
JP5806466B2 (ja) * 2008-01-28 2015-11-10 バイオメット・３アイ・エルエルシー 親水性を向上させたインプラント表面
WO2012149451A1 (en) * 2011-04-28 2012-11-01 Abraxis Bioscience, Llc Intravascular delivery of nanoparticle compositions and uses thereof
CN102763642B (zh) * 2012-08-14 2014-04-02 郑州赛英科干细胞技术有限公司 一种冷冻保护液以及冷冻保存人胎盘羊膜和绒毛膜的方法
CN107670109A (zh) * 2014-05-27 2018-02-09 诺瓦赫普有限公司 经生物工程改造的同种异体瓣膜
AU2016228986B2 (en) * 2015-03-10 2021-02-04 Stent Tek Limited Surgical system, device and methods of use thereof for the percutaneous creation of an arteriovenous fistula (AVF)
US12017032B1 (en) 2017-11-13 2024-06-25 Sbr Innovations, Llc Arteriovenous graft and method of using thereof
US11389622B1 (en) * 2017-11-13 2022-07-19 Simon B. Rayhanabad Patch for providing dialysis
US11918223B2 (en) 2018-02-02 2024-03-05 University Of Louisville Research Foundation, Inc. Sutureless graft anastomotic quick connect system
IL311092B2 (en) * 2018-08-31 2025-05-01 Wisconsin Alumni Res Found Fabrication of vascular grafts seeded with arterial endothelial cells
US12310836B2 (en) 2020-03-03 2025-05-27 Akeo Hagiwara Vein cover
CN115376392B (zh) * 2022-08-18 2024-04-26 昆明理工大学 主动脉老化对血管生物力学影响的模拟装置及方法
EP4439070B1 (de) * 2023-03-27 2025-12-03 Siemens Healthcare Diagnostics Products GmbH Automatisches analysesystem
CN120227529B (zh) * 2025-05-29 2025-08-12 鼎科医疗技术（苏州）有限公司 一种血管外支架

Family Cites Families (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4418691A (en) * 1981-10-26 1983-12-06 Massachusetts Institute Of Technology Method of promoting the regeneration of tissue at a wound
US4787900A (en) * 1982-04-19 1988-11-29 Massachusetts Institute Of Technology Process for forming multilayer bioreplaceable blood vessel prosthesis
US4820626A (en) * 1985-06-06 1989-04-11 Thomas Jefferson University Method of treating a synthetic or naturally occuring surface with microvascular endothelial cells, and the treated surface itself
IL78950A (en) 1985-06-06 1991-12-15 Univ Jefferson Coating for prosthetic devices
US4732155A (en) * 1985-08-27 1988-03-22 The Children's Medical Center Corporation Implantable chemoattractant system
US5863531A (en) * 1986-04-18 1999-01-26 Advanced Tissue Sciences, Inc. In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework
US6309635B1 (en) * 1986-11-20 2001-10-30 Children's Medical Center Corp. Seeding parenchymal cells into compression resistant porous scaffold after vascularizing in vivo
CA1340581C (en) * 1986-11-20 1999-06-08 Joseph P. Vacanti Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices
US5567612A (en) * 1986-11-20 1996-10-22 Massachusetts Institute Of Technology Genitourinary cell-matrix structure for implantation into a human and a method of making
US5804178A (en) * 1986-11-20 1998-09-08 Massachusetts Institute Of Technology Implantation of cell-matrix structure adjacent mesentery, omentum or peritoneum tissue
US5736372A (en) * 1986-11-20 1998-04-07 Massachusetts Institute Of Technology Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure
US5073492A (en) * 1987-01-09 1991-12-17 The Johns Hopkins University Synergistic composition for endothelial cell growth
US5145769A (en) * 1987-08-21 1992-09-08 Cryolife Inc. Method for cryopreserving blood vessels
US5202120A (en) * 1987-09-11 1993-04-13 Case Western Reserve University Methods of reducing glial scar formation and promoting axon and blood vessel growth and/or regeneration through the use of activated immature astrocytes
US4945086A (en) 1988-05-03 1990-07-31 The Board Of Trustees Of The Leland Stanford Junior University Smooth muscle cell growth inhibitor
US5575815A (en) * 1988-08-24 1996-11-19 Endoluminal Therapeutics, Inc. Local polymeric gel therapy
US5843156A (en) * 1988-08-24 1998-12-01 Endoluminal Therapeutics, Inc. Local polymeric gel cellular therapy
CH676195A5 (enExample) * 1988-10-07 1990-12-28 Sulzer Ag
JPH03133901A (ja) * 1989-10-19 1991-06-07 Osaka Gas Co Ltd 生体細胞の凍結保存方法
US5527532A (en) * 1989-11-13 1996-06-18 President And Fellows Of Harvard College Extraluminal regulation of the growth and repair of tubular structures in vivo
WO1991007154A1 (en) * 1989-11-13 1991-05-30 President And Fellows Of Harvard College EXTRALUMINAL REGULATION OF THE GROWTH AND REPAIR OF TUBULAR STRUCTURES ιIN VIVO
US5540928A (en) * 1991-02-27 1996-07-30 President And Fellows Of Harvard College Extraluminal regulation of the growth and repair of tubular structures in vivo
CA2071137A1 (en) * 1991-07-10 1993-01-11 Clarence C. Lee Composition and method for revitalizing scar tissue
CA2113089C (en) 1991-07-15 2007-11-06 Peter J. Sims Universal donor cells
US5336615A (en) 1992-01-06 1994-08-09 Yale University Genetically engineered endothelial cells exhibiting enhanced migration and plasminogen activator activity
JPH0646840A (ja) * 1992-08-04 1994-02-22 Nippon Zenyaku Kogyo Kk 細胞凍結保存液
US5399665A (en) * 1992-11-05 1995-03-21 Massachusetts Institute Of Technology Biodegradable polymers for cell transplantation
US5981568A (en) * 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6491938B2 (en) * 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
GB9306449D0 (en) * 1993-03-29 1993-05-19 Nat Heart Research Fund Tissue equivalents
US5709854A (en) * 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
US5645829A (en) * 1993-06-18 1997-07-08 Beth Israel Hospital Association Mesothelial cell gene therapy
US6176874B1 (en) * 1993-10-18 2001-01-23 Masschusetts Institute Of Technology Vascularized tissue regeneration matrices formed by solid free form fabrication techniques
US6608182B1 (en) * 1994-03-08 2003-08-19 Human Genome Sciences, Inc. Human vascular endothelial growth factor 2
AU2399495A (en) 1994-04-29 1995-11-29 W.L. Gore & Associates, Inc. Improved blood contact surfaces using endothelium on a subendothelial extracellular matrix
US5834029A (en) * 1994-07-20 1998-11-10 Cytotherapeutics, Inc. Nerve guidance channel containing bioartificial three-dimensional hydrogel extracellular matrix derivatized with cell adhesive peptide fragment
ES2155534T3 (es) * 1994-10-12 2001-05-16 Focal Inc Administracion dirigida por medio de polimeros biodegradables.
US6911216B1 (en) * 1994-10-12 2005-06-28 Genzyme Corporation Targeted delivery via biodegradable polymers
US5914268A (en) * 1994-11-21 1999-06-22 National Jewish Center For Immunology & Respiratory Medicine Embryonic cell populations and methods to isolate such populations
US5716404A (en) * 1994-12-16 1998-02-10 Massachusetts Institute Of Technology Breast tissue engineering
US6281015B1 (en) * 1994-12-16 2001-08-28 Children's Medical Center Corp. Localized delivery of factors enhancing survival of transplanted cells
US5855610A (en) * 1995-05-19 1999-01-05 Children's Medical Center Corporation Engineering of strong, pliable tissues
US5766584A (en) * 1995-06-02 1998-06-16 Massachusetts Institute Of Technology Inhibition of vascular smooth muscle cell proliferation with implanted matrix containing vascular endothelial cells
US6615071B1 (en) * 1995-09-20 2003-09-02 Board Of Regents, The University Of Texas System Method and apparatus for detecting vulnerable atherosclerotic plaque
US5897987A (en) * 1996-03-25 1999-04-27 Advanced Reproduction Technologies, Inc. Use of arabinogalactan in cell cryopreservation media
US6886568B2 (en) * 1998-04-08 2005-05-03 The Johns Hopkins University Method for fabricating cell-containing implants
AU766693B2 (en) * 1998-11-24 2003-10-23 Emory University Transgenic circulating endothelial cells
US6328762B1 (en) * 1999-04-27 2001-12-11 Sulzer Biologics, Inc. Prosthetic grafts
US6387116B1 (en) * 1999-06-30 2002-05-14 Pharmasonics, Inc. Methods and kits for the inhibition of hyperplasia in vascular fistulas and grafts
US6461631B1 (en) * 1999-11-16 2002-10-08 Atrix Laboratories, Inc. Biodegradable polymer composition
AU2001243248A1 (en) * 2000-02-23 2001-09-03 Smith Kline Beecham Corporation Method for the prevention or reduction of vascular access dysfunction
DE60130544T2 (de) * 2000-03-13 2008-06-26 Biocure, Inc. Embolische zusammensetzungen
WO2001068158A1 (en) * 2000-03-15 2001-09-20 Orbus Medical Technologies Inc. Coating that promotes endothelial cell adherence
KR20020086678A (ko) * 2000-03-24 2002-11-18 가부시끼가이샤 메니콘 조직 등가물의 동결 보존 방법 및 동결 보존된 조직 등가물
US6506398B1 (en) * 2000-04-28 2003-01-14 Hosheng Tu Device for treating diabetes and methods thereof
US20020042131A1 (en) * 2000-06-09 2002-04-11 Organ Recovery Systems Cryopreservation method using cryoprotective composition of propanediol and a vehicle solution
AU2001277112A1 (en) 2000-07-21 2002-02-05 Board Of Regents, The University Of Texas System Device providing regulated growth factor delivery for the regeneration of peripheral nerves
WO2002028387A1 (en) * 2000-10-03 2002-04-11 Oncopharmaceutical, Inc. Inhibitors of angiogenesis and tumor growth for local and systemic administration
JP2002200161A (ja) * 2000-10-24 2002-07-16 Menicon Co Ltd 培養皮膚代替物の製造方法およびそれにより得られる培養皮膚代替物
US6565601B2 (en) * 2000-11-15 2003-05-20 Micro Therapeutics, Inc. Methods for vascular reconstruction of diseased arteries
EP1389078A4 (en) * 2000-12-27 2004-03-17 Ortec International Inc METHOD FOR THE PRODUCTION OF CRYCONSERVED COMPOSED LIVING CONSTRUCTS AND PRODUCTS PRODUCED FROM THEM
ES2621652T3 (es) * 2001-01-16 2017-07-04 Vascular Therapies, Inc. Dispositivo implantable que contiene material de matriz reabsorbible y rapamicina para evitar o tratar enfermedades vasculoproliferativas
US6723131B2 (en) * 2001-02-28 2004-04-20 The Cleveland Clinic Foundation Composite bone marrow graft material with method and kit
WO2003026489A2 (en) 2001-09-28 2003-04-03 University Of Florida Biopolymer and biopolymer-cell compositions for nerve tissue repair
US7297540B2 (en) * 2002-01-15 2007-11-20 Yissum Research Development Company Of The Hebrew University Of Jerusalem Methods of generating tissue using devitalized, acellular scaffold matrices derived from micro-organs
US20040047843A1 (en) * 2002-02-12 2004-03-11 Uab Research Foundation Method for spinal cord reconnection
WO2003083044A2 (en) * 2002-03-25 2003-10-09 Condros, Inc. Tissue analogs for in vitro testing and method of use therefor
US20050008629A1 (en) * 2002-05-08 2005-01-13 Interpore Orthopaedics, A Delaware Corporation Encapsulated AGF cells
AU2003250858A1 (en) * 2002-06-28 2004-01-19 Novartis Ag Use of organic compounds
FR2845691B1 (fr) * 2002-10-10 2004-12-10 Centre Nat Rech Scient Nouvelles cellules endotheliales, anticorps diriges contre ces cellules et leur utilisation, notamment pour le criblage de substances inhibant l'angiogenese
US20040156878A1 (en) * 2003-02-11 2004-08-12 Alireza Rezania Implantable medical device seeded with mammalian cells and methods of treatment
WO2004111207A1 (en) * 2003-06-09 2004-12-23 Centelion Multicellular in vitro model of angiogenesis and methods for using the same
US8192348B2 (en) * 2003-07-01 2012-06-05 Regents Of The University Of Minnesota Engineered blood vessels
GB0322789D0 (en) * 2003-09-30 2003-10-29 Lifeforce Group Plc Blood pack for leukocyte banking
US20050106554A1 (en) * 2003-11-19 2005-05-19 Palecek Sean P. Cryopreservation of pluripotent stem cells
US8067368B2 (en) * 2004-01-27 2011-11-29 The Ohio State University Research Foundation Vascular endothelial growth factors and methods of their use
ATE506431T1 (de) * 2004-04-23 2011-05-15 Bioe Llc Mehrfachlinien-vorläuferzellen
FR2869533B1 (fr) 2004-05-03 2006-07-28 Sedat Sa Seringue pour interventions medicales et necessaire de reconstitution de substances extemporanees comportant une telle seringue
US7842304B2 (en) 2004-10-29 2010-11-30 Nexeon Medsystems, Inc. Methods and apparatus for treating an injured nerve pathway
WO2006062871A2 (en) 2004-12-08 2006-06-15 Pervasis Therapeutics, Inc. Materials and methods for minimally-invasive administration of a cell-containing flowable composition
DE602005022481D1 (de) 2004-12-08 2010-09-02 Pervasis Therapeutics Inc Zusammensetzungen und deren verwendung für besseren gefässzugang
WO2006062909A2 (en) * 2004-12-08 2006-06-15 Pervasis Therapeutics, Inc. Methods and compositions for enhancing vascular access
AU2006238892B2 (en) 2005-04-21 2011-01-27 Massachusetts Institute Of Technology Materials and methods for altering an immune response to exogenous and endogenous immunogens, including syngeneic and non-syngeneic cells, tissues or organs
GB0509845D0 (en) 2005-05-13 2005-06-22 Btg Int Ltd Preparation of therapeutic foam
US20090035346A1 (en) 2005-06-21 2009-02-05 Pervasis Therpeutics, Inc. Methods and Compositions for Enhancing Vascular Access
JP5015160B2 (ja) 2005-10-12 2012-08-29 セルラー・バイオエンジニアリング・インコーポレイテッド 再吸収可能な角膜ボタン（ｒｅｓｏｒｂａｂｌｅｃｏｒｎｅａｂｕｔｔｏｎ）
US7882863B2 (en) * 2005-10-19 2011-02-08 Cd Solutions, Llc Apparatus and method for mixing and transferring medications
AU2006348410B2 (en) * 2005-11-07 2011-12-15 Industrie Borla S.P.A. Vented safe handling vial adapter

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2926510B2 (ja) 1990-08-09 1999-07-28 京都電子工業株式会社 アンモニア濃度測定装置

Also Published As

Publication number Publication date
US9023377B2 (en) 2015-05-05
CA2818182C (en) 2015-04-14
CN101878757A (zh) 2010-11-10
JP2008546406A (ja) 2008-12-25
IL188263A0 (en) 2009-02-11
ES2541684T3 (es) 2015-07-23
SG161258A1 (en) 2010-05-27
WO2007001744A2 (en) 2007-01-04
CN102743792B (zh) 2014-09-24
US20130210142A1 (en) 2013-08-15
US20090035346A1 (en) 2009-02-05
SG195537A1 (en) 2013-12-30
IL220806A0 (en) 2012-08-30
EP1901680B1 (en) 2015-04-15
CN101257861A (zh) 2008-09-03
EP2361591A3 (en) 2011-12-21
CA2612751A1 (en) 2007-01-04
EP2361591A2 (en) 2011-08-31
WO2007001744B1 (en) 2007-12-21
CA2818182A1 (en) 2007-01-04
IL188263A (en) 2014-05-28
WO2007001744A3 (en) 2007-10-04
AU2006262682A1 (en) 2007-01-04
EP1901680A2 (en) 2008-03-26
AU2006262682B2 (en) 2012-07-05
CN102743792A (zh) 2012-10-24
JP2012166084A (ja) 2012-09-06
IL220806A (en) 2014-05-28
CN101257861B (zh) 2012-12-05

Similar Documents

Publication Publication Date Title
AU2005314263B2 (en) Methods and compositions for enhancing vascular access
JP2012166084A (ja) 脈管アクセスを改善するための方法および組成物
US20100204783A1 (en) Methods and compositions for enhancing vascular access
ES2348961T3 (es) Composiciones y su uso para aumentar el acceso vascular.
WO2006062909A2 (en) Methods and compositions for enhancing vascular access
AU2012238220B2 (en) Methods and compositions for enhancing vascular access
AU2011211370B2 (en) Methods and compositions for enhancing vascular access
HK1143517A (en) Compositions and their use for enhancing vascular access
HK1174859A (en) Methods and compositions for enhancing vascular access
HK1178466A (en) Methods and compositions for enhancing vascular access
HK1112429B (en) Compositions and their use for enhancing vascular access

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090528

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090528

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100524

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20111212

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120309

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120312

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120316

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120319

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120612

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120723

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121122

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20130118

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20130212

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130416

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130716

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20130816

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140825

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20141010

R150 Certificate of patent or registration of utility model

Ref document number: 5632580

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees